Inhibitory Role of Dopaminergic D2 Receptors in the Expression of Glutamic Acid Decarboxylase and Preproenkephalin mRNA in the Rat Striatum
Dopamine (DA) contained in the dense network of DA fibers innervating the striatum has been shown to play a major role in the regulation of striatal neuron activity. This has been approached by analyzing either changes in electrophysiological properties of neurons (Bernardi et al., 1978; Calabresi et al., 1988) or changes in biochemical parameters such as the levels and/or the synthesis (Hong et al., 1978a and b; Hanson et al., 1988; Li et al., 1987) or the release (Lehman and Langer, 1983; Girault et al., 1986a) of specific neurotransmitters localized in striatal neurons. A useful tool in understanding the regulation of neuronal activity is now offered by molecular biology which allows the identification of specific mRNAs, reflecting earlier events than neurotransmitter contents. In this study, we tried to elucidate the DA receptor subtype which mediates dopaminergic modulation of the expression of messengers encoding glutamic acid decarboxylase (GAD) and preproenkephalin (PPE), two major markers contained in projection neurons of the striatum (Fonnum et al., 1974; Cuello et al. 1978). This analysis has been initiated by previous findings showing that a 6-hydroxydopamine (6-OHDA) lesion of nigrostriatal DA neurons produced increased levels of mRNAs encoding GAD (Vernier et al., 1988) and PPE (Angulo et al. 1986; Young et al., 1986; Normand et al. 1988), and that these effects could be reproduced by chronic treatments with haloperidol (Sabol et al., 1983; Tang et al., 1983; Sivam et al., 1986; Normand et al., 1987; Morris et al., 1988; Vernier unpublished observations). These previous studies suggested an inhibitory control of DA on the expression of both GAD- and PPE-mRNA. The action of DA being mediated by an interaction with at least two receptor subtypes, coupled to different second messenger systems (Stoof and Kebabian, 1981), it was of interest to elucidate the receptor subtype involved in these effects.
KeywordsVentral Striatum Glutamic Acid Decarboxylase Dorsal Striatum Striatal Neuron Striatopallidal Neuron
Unable to display preview. Download preview PDF.
- Björklund, A., and Lindvall, O., Dopamine-containing systems in the CNS., 1984, "Handbook of Chemical Neuroanatomy, Vol. 2, Classical Neurotransmitters in the CNS", Björklund A. and Hökfelt T. eds, Part I, pp. 55–112. Elsevier, Amsterdam.Google Scholar
- Boyson, S.J., Mc Gonigle, P., and Molinoff, P.B., 1986, Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain, L Neurosci., 6: 3177 – 3188.Google Scholar
- Dawson, T.M., Gehlert, D.R., McCabe, R.T., Barnett, A., and Wamsley, J.K., 1986, D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis, J. Neurosci., 6: 2353 – 2365.Google Scholar
- Faucon Biguet, N., Buda, M., Lamouroux, A., Samolyk D., and Mallet, J., 1986, Time course of the changes of TH mRNA in rat brain and adrenal medulla after a single injection of reserpine, EMBO J., 5: 287 – 291.Google Scholar
- Fonnum, F., Gottesfeld, Z., and Grofova, I., 1974, Distribution of glutamate decarboxylase, choline acetyltransferase and aromatic amino-acid decarboxylase in the basal ganglia of normal and operated rats: evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibers, Brain Res. 143: 125 – 138.CrossRefGoogle Scholar
- Girault, J.A., Spampinato, U., Savaki, H.E., Glowinski, J., and Besson, M.J., 1986a, In vivo release of (3H)o-aminobutyric acid in the rat neostriatum - I.Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents, Neuroscience, 19: 1101–1108.PubMedCrossRefGoogle Scholar
- Girault, J.A., Barbeito, L., Spampinato, U., Gozlan, H., Glowinski, J., and Besson, M.-J., 1986b, In vivo release of endogenous amino acids from the rat striatum: further evidence for a role of glutamate and aspartate in corticostriatal neurotransmission, J. Neurochem., 47: 98 – 106.CrossRefGoogle Scholar
- Hong, J.S., Yang, H.-Y. T., Fratta, W., and Costa E., 1978a, Rat striatal methionineenkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs, J. Pharmacol. exp. Ther., 205: 141 – 147.Google Scholar
- Li, S., Sivam, S.P., McGinty, J.F., Huang Y.S., and Hong, J.S., 1987, Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway, k Pharmacol. Exp. Ther., 243: 792 – 798.Google Scholar
- Sivam, S.P., Strunk, C., Smith, D.R., and Hong, J.S., 1986, Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol, Molec. Pharmacol., 30: 186–191.Google Scholar
- Uhl, G.R., Navia, B., and Douglas, J., 1988, Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents, L Neurosci., 8: 4755 – 4564.Google Scholar